Radioimmunoscintigraphy with Technetium-99m-labelled Monoclonal Antibody, SM3, in Gynaecological Cancer
Overview
Authors
Affiliations
Radioimmunoscintigraphy (RIS) with technetium-99m labelled SM3, a monoclonal antibody reacting with a polymorphic epithelial mucin glycoprotein core antigen, is evaluated. No adverse effects or thyroid uptake were observed. Studies in 45 patients (one twice) had a sensitivity for gynaecological malignancy of 100% (35/35) and a specificity of 73% (8/11), giving an overall accuracy of 93% (43/46). These results have led to the routine adoption of 99mTc RIS in the management of patients suspected of or having primary or recurrent gynaecological cancer.
Recent trends in antibody-based oncologic imaging.
Kaur S, Venktaraman G, Jain M, Senapati S, Garg P, Batra S Cancer Lett. 2011; 315(2):97-111.
PMID: 22104729 PMC: 3249014. DOI: 10.1016/j.canlet.2011.10.017.
Biassoni L, Granowska M, Carroll M, Mather S, Howell R, Ellison D Br J Cancer. 1998; 77(1):131-8.
PMID: 9459158 PMC: 2151258. DOI: 10.1038/bjc.1998.21.
Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri M, Mather S Eur J Nucl Med. 1996; 23(2):178-87.
PMID: 8925853 DOI: 10.1007/BF01731842.
Sakahara H, Hosono M, Kobayashi H, Yao Z, Saga T, Yano S Jpn J Cancer Res. 1996; 87(6):655-61.
PMID: 8766531 PMC: 5921138. DOI: 10.1111/j.1349-7006.1996.tb00273.x.
Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.
Ind T, Granowska M, Britton K, Morris G, Lowe D, Hudson C Br J Cancer. 1994; 70(6):1263-6.
PMID: 7981086 PMC: 2033666. DOI: 10.1038/bjc.1994.484.